MedTrace Logo

Early Goal-Directed Therapy Utilizing Transpulmonary Thermodilution and Severe Burn Injury

NCT05420610 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 66

Last updated 2022-06-15

No results posted yet for this study

Summary

This study aimed to optimize fluid resuscitation with transpulmonary thermodilution (TPTD)-guided protocol and to lower the mortality rate of the severely burned.

Conditions

  • Burns

Interventions

OTHER

Control group: Patients being admitted when The advancement of transpulmonary thermodilution(TPTD) device was unavailable.

The control group included patients being admitted when TPTD device was unavailable; and relatively stable patients without the need for TPTD. The adequacy of fluid resuscitation in the control group was monitored by traditional monitoring parameters including vital signs and hourly urine output.

OTHER

Study group: TPTD device was implemented for monitoring.

TPTD device was implemented for monitoring; the inclusion criteria included patients suffering from 2nd degree burn greater than 40% TBSA; a combined 2nd to 3rd degree burn greater than 30% TBSA; or patients with inhalation injury despite the burned surface area.

Sponsors & Collaborators

  • Chang Gung Memorial Hospital

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
100 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-08-07
Primary Completion
2021-11-30
Completion
2022-01-20

Countries

  • Taiwan

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05420610 on ClinicalTrials.gov